The global nicotine pouch market hit nearly $7 billion in 2025 — and retail sales surpassed 23 billion units, growing more than 50% year-on-year. That explosive growth is reshaping the industry at every level, from a landmark FDA enforcement shift in the United States to a blocked EU tax reform that is good news for European prices. Here is everything that matters for buyers in 2026.
Key Takeaways
- Global market reached ~$7 billion in 2025 (World Health Organization data, May 2026)
- Retail sales exceeded 23 billion units in 2024 — up 50%+ year-on-year
- US FDA issued new enforcement guidance in May 2026, expanding market access for flavoured pouches
- Sweden vetoed EU tobacco tax modernisation at ECOFIN on 12 June 2026 — no EU-wide price increases this year
- ZYN ULTRA launched in the US on 15 June 2026 with 20 pouches per can at 9mg and 11mg
A $7 Billion Category: The Numbers Behind the Boom
The figures released by the World Health Organization in May 2026 confirmed what the industry already knew: nicotine pouches are not a niche product anymore. Retail sales crossed 23.4 billion units globally in 2024 — a single-year increase of more than 50%. According to a report from Stanford Medicine published in collaboration with the WHO, the global market value stood at nearly $7 billion in 2025, with the United States accounting for close to 80% of that revenue.
Forward projections are equally striking. Independent market analysis from Persistence Market Research estimates the sector will be worth $9.5 billion in 2026, growing to $44.79 billion by 2033 at a compound annual growth rate (CAGR) of 24.8%. For context: US monthly nicotine pouch sales stood at $145.5 million in January 2023. By August 2025, that figure had reached $510.5 million per month — a 250% jump in under three years.
Europe is the category's most important emerging market. While the US dominates by revenue, Scandinavia, Germany, Poland, and the UK are all growing fast. Brands are building distribution, expanding flavour ranges, and competing aggressively on price to capture European market share that is still very much up for grabs.
See which brands are winning right now at The Snus Outlet's 2026 best-sellers collection — with EU delivery in 2–7 days and free shipping on orders over €99.
FDA Enforcement Shift: What Changed in May 2026
On 8 May 2026, the US Food and Drug Administration issued updated guidance that significantly changed the regulatory environment for nicotine pouches. The FDA announced it would apply enforcement discretion — meaning it would not prioritise removing products from market — for nicotine pouches whose manufacturers have a Premarket Tobacco Application (PMTA) accepted and under active scientific review.
In plain terms: flavoured pouches from brands with applications in the pipeline can stay on shelves while the FDA completes its work. The previous framework had required full authorisation before any product could legally reach consumers, creating a significant bottleneck. Industry analysts at Barclays estimated 100–200 products could immediately benefit from the change.
The only nicotine pouch brand with full FDA marketing authorisation remains ZYN, with 20 products cleared in January 2025 following an extensive scientific review. ZYN has also submitted a Modified Risk Tobacco Product (MRTP) application — which, if approved, would allow it to market itself as a reduced-risk product compared to cigarettes. The FDA is currently reviewing that application; the public comment period closed in March 2026.
For European consumers, the FDA shift matters because it signals where global regulation is heading. As the world's largest nicotine pouch market opens further, production investment follows — which ultimately improves availability and competitive pricing across all markets, including Europe.
ZYN ULTRA: What the New Format Changes
Philip Morris International officially launched ZYN ULTRA in the United States on 15 June 2026, distributed through Haypp Group's platforms Nicokick.com and Northerner.com. The new format makes two meaningful upgrades: 20 pouches per can instead of the standard 15, and a lower price-per-pouch that undercuts the flagship ZYN range significantly.
The initial launch covers eight flavours at 9mg — Arctic Mint, Peppermint, Fresh Mint, Citrus, Menthol, Smooth, and Chill Mist — with an 11mg version planned for later in June. The launch is partly a competitive response to VELO Plus from British American Tobacco, which has been gaining market share in the moist-format segment.
PMI is simultaneously doubling production capacity at its Kutná Hora plant in the Czech Republic, raising total investment from $40 million to $80 million and creating up to 150 jobs. That Czech plant is becoming PMI's primary European ZYN manufacturing hub — a strong signal that ZYN supply into European markets will increase through 2026 and 2027. European buyers should expect expanded ZYN availability and potentially improved pricing as capacity scales.
EU Tobacco Tax Reform Blocked: Good News for European Prices
European nicotine pouch buyers received a significant piece of good news on 12 June 2026: Sweden exercised its veto at the ECOFIN Council meeting, forcing the EU's planned tobacco and nicotine tax modernisation off the agenda entirely.
The proposed reform would have updated a decade-old EU framework governing excise duties on tobacco and nicotine products — and could have led to notable price increases across member states. Sweden's objection is principled and consistent: nicotine pouches and snus are harm-reduction tools and should not face the same tax burden as combustible tobacco. Because EU tax legislation requires unanimous approval from all member states, Sweden's single veto is a hard block, not a procedural delay.
The issue moves to the Irish Presidency to attempt a new compromise. For now, no EU-wide tax increase on nicotine pouches will happen in 2026. Individual countries can still act independently — Poland introduced a national excise tax in August 2025, and Portugal added a levy in early 2026 — but cross-border purchases from online retailers remain unaffected by those national-level changes.
Sports, Celebrities and the Mainstream Moment
One of the clearest indicators that nicotine pouches have gone fully mainstream: celebrity and sports investment is accelerating in 2026. In April 2026, FRE Nicotine Pouches became the UFC's first official nicotine pouch partner, with branding appearing at all US numbered and Fight Night events. The deal extends across TKO Group Holdings properties including Zuffa Boxing, World's Strongest Man, and Formula Drift.
Celebrity investor interest is equally visible. DJ Diplo has publicly discussed his stake in Sesh, a tobacco-free pouch brand. The Jonas Brothers (Nick and Joe Jonas), Post Malone, and The Chainsmokers have all reported investments in nicotine pouch ventures. ZYN meanwhile extended its Ducati Corse partnership, putting ZYN branding on MotoGP race liveries at select 2026 events — a premium positioning play that mirrors how sports sponsorship elevated energy drinks in the early 2000s.
For European buyers, this cultural moment has a practical implication: more investment, more innovation, and more competition between brands. All of that points toward better products at better prices.
Where the Major Brands Stand in 2026
| Brand | Parent Company | 2026 Key Developments | Strengths Available |
|---|---|---|---|
| ZYN | Philip Morris International | FDA authorised; ZYN ULTRA launched; Czech production doubled; MotoGP partnership | 3mg, 6mg, 9mg, 11mg |
| VELO | British American Tobacco | Strongest European retail footprint outside Scandinavia; US patent case lost vs PMI | 4mg, 6mg, 10mg, 14mg |
| LOOP | Nordic Snus AB | Dual-release format; Jalapeno Lime and Salty Liquorice remain signature SKUs | 6mg, 10mg, 16mg |
| ZEUS | Vivasnus (Latvia) | Growing European challenger; competitive pricing across strength tiers | 6mg, 12mg, 25mg |
| XQS | XQS Nordic | Widest flavour catalogue in category; aggressive value pricing in online channel | 4mg, 6mg, 10mg, 16mg |
| KUMA | Independent | Best-value positioning; popular with buyers switching from higher-priced brands | 4mg, 6mg, 10mg |
Browse ZYN's full range at The Snus Outlet, alongside VELO, LOOP, ZEUS, XQS and KUMA — all strengths, all flavours, stocked and ready for EU delivery.
Frequently Asked Questions
How big is the global nicotine pouch market in 2026?
According to WHO data from May 2026, the global market was worth nearly $7 billion in 2025. Independent market research estimates the figure will reach $9.5 billion in 2026, with a projected CAGR of 24.8% taking the market to $44.79 billion by 2033. Retail unit sales exceeded 23 billion pouches in 2024 — a 50%+ year-on-year increase.
What did the FDA change about nicotine pouches in May 2026?
The FDA issued new enforcement guidance on 8 May 2026, stating it would not prioritise enforcement against nicotine pouches whose manufacturers have a Premarket Tobacco Application (PMTA) accepted and under active scientific review. This allows flavoured and pending-authorisation products to remain on the US market while reviews continue. ZYN remains the only brand with full FDA marketing authorisation, granted in January 2025.
Will the EU raise taxes on nicotine pouches in 2026?
No — not at the EU level. Sweden vetoed the EU tobacco and nicotine tax reform at the ECOFIN meeting on 12 June 2026. Because EU tax legislation requires unanimous agreement, the reform is blocked until a new compromise is negotiated. Individual countries (Poland, Portugal) have their own national excise taxes, but these do not affect cross-border purchases from online retailers like The Snus Outlet.
What is ZYN ULTRA and when will it arrive in Europe?
ZYN ULTRA is a new ZYN format featuring 20 pouches per can — five more than the standard range — at a lower price per pouch. It launched in the US on 15 June 2026 in 9mg across eight flavours, with 11mg following later in June. No European release date has been confirmed, but PMI is doubling production capacity at its Czech Republic plant specifically to serve European markets, suggesting availability will expand through late 2026.
Which nicotine pouch brands are growing fastest in Europe?
ZYN leads globally, but in the European online channel, VELO, LOOP, ZEUS, and XQS are all posting strong growth. Scandinavian brands like LOOP and XQS benefit from local production, competitive pricing, and distinctive formats. ZEUS and KUMA are gaining traction among value-focused buyers. Disposable vape bans in the UK (June 2025) and Belgium are also driving new users toward nicotine pouches, expanding the total buyer pool.
Final Thoughts
The nicotine pouch industry is at an inflection point. The numbers — $7 billion in 2025, 23 billion units sold, 50%+ annual growth — tell a story of a product category that has gone from Scandinavian curiosity to global phenomenon in under a decade. The FDA is opening the US market further, the EU tax threat has been neutralised for now, and brands are investing at record levels to serve a growing European buyer base.
For buyers, this translates into more choice, better formats, and sharper prices. Browse the full range at our outlet deals collection — top brands at up to 60% off, with free EU shipping on orders over €99.


Share:
Nicotine Pouches and the World Cup 2026: The Football Fan's Complete Guide
C.R.E.A.M Nicotine Pouches Flavours Ranked: Every Flavour Reviewed